Cathinone is the main psychoactive compound derived from the leaves of the shrub Khat (Catha edulis). The Khat plant is native to East Africa and the Arabian Peninsula, and residents of those regions have, for centuries, chewed or brewed Khat leaves for their stimulant properties (Capriola, 2013). Cathinone shares the phenethylamine structure of amphetamine and, along with that, its psychostimulant effects (Baumann et al., 2018;Simmons et al., 2018;Riley et al., 2020). Although chewing Khat leaves is seen as commonplace and relatively nonproblematic in some regions of the world, more recently, synthetic derivatives of cathinone entered the recreational drug market and have proven to be problematic. Around 2009, clandestine laboratories began altering the structure of cathinone to produce derivatives with pharmacodynamic, pharmacokinetic, and potency profiles that aligned with high abuse potential as well as high toxicity. These synthetic cathinones, including 4-methylmethcathinone (mephedrone), 3,4-methylenedioxypyrovalerone (MDPV), and 3,4methylenedioxymethcathinone (methylone), were aggressively marketed internationally, had a legal status, and were readily available and affordable to consumers. As a result, their popularity as recreational stimulants rose accordingly. Synthetic cathinones were sold on the internet and at "smart shops," "head shops," and other retail establishments as fictitious products labeled as "bath salts," "plant food," or "fertilizer" and marked "not for human consumption" to bypass Food and Drug Administration regulations (Riley et al., 2020;Soares et al., 2021). Within a few years, their use in the United States, Europe, and other parts of the world had grown, along with an alarming increase in calls to poison control centers and reports of their harmful effects, including death (LaMaida et al., 2021). Because of "an imminent threat to public safety," mephedrone, MDPV, methylone, and their isomers were placed in Schedule I of the Controlled Substance Act in 2011 by the Drug Enforcement Administration through emergency scheduling (Bonson et al., 2019). As specific chemical entities became scheduled, new synthetic cathinone derivatives were found on the market as reported by the National Forensic Laboratory. This trend has continued, with the synthesis and release of a variety of novel compounds based on the cathinone structure occurring at an alarming rate world wide (Riley et al., 2020;Soares et al., 2021).